Twelve Points Wealth Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Twelve Points Wealth Management's AMGN Position: Q2 2026 in Review
Twelve Points Wealth Management increased its Amgen (AMGN) stake by 6.1% in Q2 2026, buying an estimated $64K and bringing the position to 3,235 shares worth $1.17M. The position accounts for 0.23% of the portfolio, ranked #85.
Twelve Points Wealth Management first reported a position in AMGN in Q1 2022 and has held it in 18 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Twelve Points Wealth Management held 3,235 shares of Amgen worth $1.17M as of Q2 2026.
- Twelve Points Wealth Management bought 187 Amgen shares in Q2 2026, an estimated $64K.
- Amgen made up 0.23% of Twelve Points Wealth Management's portfolio in Q2 2026, its #85 holding.
- Twelve Points Wealth Management first reported a position in Amgen in Q1 2022 and has held it in 18 quarters since.
- 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Twelve Points Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.